South Korea Mammalian Cell Fermentation Technology Market Size & Outlook
South Korea mammalian cell fermentation technology market, 2018-2030 (US$M)
Related Markets
South Korea mammalian cell fermentation technology market highlights
- The South Korea mammalian cell fermentation technology market generated a revenue of USD 1,088.5 million in 2023 and is expected to reach USD 1,706.7 million by 2030.
- The South Korea market is expected to grow at a CAGR of 6.6% from 2024 to 2030.
- In terms of segment, chinese hamster ovary (cho) cell fermentation was the largest revenue generating type in 2023.
- Human Embryonic Kidney (HEK) Cell Fermentation is the most lucrative type segment registering the fastest growth during the forecast period.
Mammalian cell fermentation technology market data book summary
| Market revenue in 2023 | USD 1,088.5 million |
| Market revenue in 2030 | USD 1,706.7 million |
| Growth rate | 6.6% (CAGR from 2023 to 2030) |
| Largest segment | Chinese hamster ovary (cho) cell fermentation |
| Fastest growing segment | Human Embryonic Kidney (HEK) Cell Fermentation |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Chinese Hamster Ovary (CHO) Cell Fermentation, Human Embryonic Kidney (HEK) Cell Fermentation, Baby Hamster Kidney (BHK) Cell Fermentation, Murine Myeloma Cell Fermentation |
| Key market players worldwide | Thermo Fisher Scientific Inc, Merck KGaA, Danaher Corp, Lonza Group Ltd, Roche Holding AG ADR, Sartorius AG, AstraZeneca PLC, Bristol-Myers Squibb Co, Amgen Inc, Gilead Sciences Inc, Moderna Inc, Regeneron Pharmaceuticals Inc |
Other key industry trends
- In terms of revenue, South Korea accounted for 2.6% of the global mammalian cell fermentation technology market in 2023.
- Country-wise, Canada is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China mammalian cell fermentation technology market is projected to lead the regional market in terms of revenue in 2030.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 7,646.3 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Mammalian Cell Fermentation Technology Market Scope
Mammalian Cell Fermentation Technology Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
South Korea mammalian cell fermentation technology market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to mammalian cell fermentation technology market will help companies and investors design strategic landscapes.
Chinese hamster ovary (cho) cell fermentation was the largest segment with a revenue share of 65.78% in 2023. Horizon Databook has segmented the South Korea mammalian cell fermentation technology market based on chinese hamster ovary (cho) cell fermentation, human embryonic kidney (hek) cell fermentation, baby hamster kidney (bhk) cell fermentation, murine myeloma cell fermentation covering the revenue growth of each sub-segment from 2018 to 2030.
- South Korea Mammalian Cell Fermentation Technology Type Outlook (Revenue, USD Million, 2018-2030)
- Chinese Hamster Ovary (CHO) Cell Fermentation
- End use
- Biopharmaceutical Companies
- CMOs & CDMOS
- Academic And Research Organizations
- End use
- Human Embryonic Kidney (HEK) Cell Fermentation
- End use
- Biopharmaceutical Companies
- CMOs & CDMOS
- Academic And Research Organizations
- End use
- Baby Hamster Kidney (BHK) Cell Fermentation
- End use
- Biopharmaceutical Companies
- CMOs & CDMOS
- Academic And Research Organizations
- End use
- Murine Myeloma Cell Fermentation
- End use
- Biopharmaceutical Companies
- CMOs & CDMOS
- Academic And Research Organizations
- End use
- Others
- End Use
- Biopharmaceutical Companies
- CMOs & CDMOS
- Academic And Research Organizations
- End Use
- Chinese Hamster Ovary (CHO) Cell Fermentation
Reasons to subscribe to South Korea mammalian cell fermentation technology market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of South Korea mammalian cell fermentation technology market databook
-
Our clientele includes a mix of mammalian cell fermentation technology market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the South Korea mammalian cell fermentation technology market , including forecasts for subscribers. This country databook contains high-level insights into South Korea mammalian cell fermentation technology market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
South Korea mammalian cell fermentation technology market size, by type, 2018-2030 (US$M)
South Korea Mammalian Cell Fermentation Technology Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
